🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
PharmaEssentia Corporation (TPE:6446)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
1,205.00
-40.00 (-3.21%)
Nov 19, 2026, 1:30 PM CST

PharmaEssentia Statistics

Total Valuation

PharmaEssentia has a market cap or net worth of TWD 499.39 billion. The enterprise value is 473.74 billion.

Market Cap499.39B
Enterprise Value 473.74B

Important Dates

The next estimated earnings date is Friday, February 26, 2027.

Earnings Date Feb 26, 2027
Ex-Dividend Date Jul 9, 2026

Share Statistics

PharmaEssentia has 414.43 million shares outstanding. The number of shares has increased by 0.26% in one year.

Current Share Class 414.43M
Shares Outstanding 414.43M
Shares Change (YoY) +0.26%
Shares Change (QoQ) +0.06%
Owned by Insiders (%) 8.11%
Owned by Institutions (%) 11.26%
Float 330.87M

Valuation Ratios

The trailing PE ratio is 54.82 and the forward PE ratio is 32.15.

PE Ratio 54.82
Forward PE 32.15
PS Ratio 20.29
PB Ratio 12.20
P/TBV Ratio 12.66
P/FCF Ratio 72.74
P/OCF Ratio 48.41
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 45.69, with an EV/FCF ratio of 69.01.

EV / Earnings 52.18
EV / Sales 19.24
EV / EBITDA 45.69
EV / EBIT 47.75
EV / FCF 69.01

Financial Position

The company has a current ratio of 5.00, with a Debt / Equity ratio of 0.03.

Current Ratio 5.00
Quick Ratio 4.61
Debt / Equity 0.03
Debt / EBITDA 0.11
Debt / FCF 0.16
Interest Coverage 402.86

Financial Efficiency

Return on equity (ROE) is 25.69% and return on invested capital (ROIC) is 58.30%.

Return on Equity (ROE) 25.69%
Return on Assets (ROA) 14.85%
Return on Invested Capital (ROIC) 58.30%
Return on Capital Employed (ROCE) 23.66%
Weighted Average Cost of Capital (WACC) 9.86%
Revenue Per Employee 187.92M
Profits Per Employee 69.31M
Employee Count 131
Asset Turnover 0.59
Inventory Turnover 1.22

Taxes

In the past 12 months, PharmaEssentia has paid 1.72 billion in taxes.

Income Tax 1.72B
Effective Tax Rate 15.93%

Stock Price Statistics

The stock price has increased by +194.75% in the last 52 weeks. The beta is 1.02, so PharmaEssentia's price volatility has been similar to the market average.

Beta (5Y) 1.02
52-Week Price Change +194.75%
50-Day Moving Average 1,229.20
200-Day Moving Average 964.34
Relative Strength Index (RSI) 45.39
Average Volume (20 Days) 3,445,311

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, PharmaEssentia had revenue of TWD 24.62 billion and earned 9.08 billion in profits. Earnings per share was 21.98.

Revenue24.62B
Gross Profit 22.81B
Operating Income 9.93B
Pretax Income 10.80B
Net Income 9.08B
EBITDA 10.14B
EBIT 9.93B
Earnings Per Share (EPS) 21.98
Full Income Statement

Balance Sheet

The company has 26.76 billion in cash and 1.11 billion in debt, with a net cash position of 25.65 billion or 61.90 per share.

Cash & Cash Equivalents 26.76B
Total Debt 1.11B
Net Cash 25.65B
Net Cash Per Share 61.90
Equity (Book Value) 40.92B
Book Value Per Share 98.74
Working Capital 28.74B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.31 billion and capital expenditures -3.45 billion, giving a free cash flow of 6.87 billion.

Operating Cash Flow 10.31B
Capital Expenditures -3.45B
Depreciation & Amortization 210.89M
Net Borrowing -185.84M
Free Cash Flow 6.87B
FCF Per Share 16.56
Full Cash Flow Statement

Margins

Gross margin is 92.67%, with operating and profit margins of 40.34% and 36.88%.

Gross Margin 92.67%
Operating Margin 40.34%
Pretax Margin 43.87%
Profit Margin 36.88%
EBITDA Margin 41.19%
EBIT Margin 40.34%
FCF Margin 27.89%

Dividends & Yields

This stock pays an annual dividend of 1.35, which amounts to a dividend yield of 0.11%.

Dividend Per Share 1.35
Dividend Yield 0.11%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 6.13%
FCF Payout Ratio 9.00%
Buyback Yield -0.26%
Shareholder Yield -0.15%
Earnings Yield 1.82%
FCF Yield 1.37%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Analyst Forecast

The average price target for PharmaEssentia is 1,481.27, which is 22.93% higher than the current price. The consensus rating is "Buy".

Price Target 1,481.27
Price Target Difference 22.93%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (3Y) 62.21%
EPS Growth Forecast (3Y) 76.25%

Stock Splits

The last stock split was on July 9, 2026. It was a forward split with a ratio of 1.10927783.

Last Split Date Jul 9, 2026
Split Type Forward
Split Ratio 1.10927783

Scores

PharmaEssentia has an Altman Z-Score of 25.46 and a Piotroski F-Score of 7.

Altman Z-Score 25.46
Piotroski F-Score 7